The Patent Finder

Acorda Therapeutics, Inc.

Also on record
Records under this name other than the patents Acorda Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 9 patents it holds.

Back to Acorda Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,943,166Methods and Compositions for Administration of TRPV1 Agonists
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,029,820Sustained release compositions of 4-aminopyridine
Formerly held
In force
 · USPTO record
In forceUSPTO record
US 9,956,266Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
Lapsed on the fee record
Ended May 1, 2026 · USPTO record
Lapsed on the fee recordEnded May 1, 2026USPTO record
US 9,951,001Hepatoprotectant Acetaminophen Mutual Prodrugs
Lapsed on the fee record
Ended Apr 24, 2026 · High confidence
Lapsed on the fee recordEnded Apr 24, 2026High confidence
US 11,235,031Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure
Lapsed on the fee record
Ended Feb 1, 2026 · USPTO record
Lapsed on the fee recordEnded Feb 1, 2026USPTO record
US 8,628,929Methods for detecting cardiac damage
Lapsed on the fee record
Ended Jan 14, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 14, 2026USPTO record
US 9,834,764Compositions and methods of using chondroitinase ABCI mutants
Lapsed on the fee record
Ended Dec 5, 2025 · USPTO record
Lapsed on the fee recordEnded Dec 5, 2025USPTO record
US 11,136,342Carbonate Prodrugs and Methods of Using the Same
Lapsed on the fee record
Ended Oct 5, 2025 · High confidence
Lapsed on the fee recordEnded Oct 5, 2025High confidence
US 9,757,429Methods for detecting cardiac damage
Lapsed on the fee record
Ended Sep 12, 2025 · USPTO record
Lapsed on the fee recordEnded Sep 12, 2025USPTO record
US 9,744,215Method for achieving desired glial growth factor 2 plasma levels
Lapsed on the fee record
Ended Aug 29, 2025 · USPTO record
Lapsed on the fee recordEnded Aug 29, 2025USPTO record
10 of 111 patents shown.
Pro members see all 111.
Pro members: see all 111 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited